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Perspective
Neglecting the Gap
As we ride a wave of renewed 
awareness of and investment in 
malaria prevention and treatment, 
it is tempting to believe that the era 
of neglect lies behind us. Although 
malaria’s comparatively high profile 
excludes it from the World Health 
Organization’s list of “neglected 
tropical diseases” (http://www.who.
int/neglected_diseases/diseases/en/), 
this technicality should not deceive 
us into thinking that malaria receives 
sufficient attention. The neglect of 
malaria persists, as uncovered by an 
analysis of malaria spending in this 
month’s PLoS Medicine [1].
Robert Snow and colleagues detail 
the alarming gap between the funds 
needed to meet internationally agreed 
goals and the resources thus far 
allocated [1]. Their comprehensive 
audit of malaria funding shows that the 
world invests only about $US1 billion 
per year, billions short of what several 
independent estimates suggest is 
necessary to achieve basic international 
goals for reducing malaria burdens 
[2,3]. Because need estimates may 
undershoot actual needs, the true gap 
may be far wider. 
In a climate rife with calls to revisit 
the goal of global malaria elimination 
and eradication, the magnitude of this 
gap is worrying. Target 8 of Goal 6 of 
the Millennium Development Goals is 
to “[h]ave halted by 2015 and begun 
to reverse the incidence of malaria 
and other major diseases” (http://
www.mdgmonitor.org/goal6.cfm). It is 
unlikely that Target 8 will be met unless 
malaria resource commitments can be 
made.
A Malaria Audit
In a field often informed by glimpses 
and guesswork, Snow and colleagues 
[1] provide a comprehensive and 
rigorous analysis of global malaria 
financing. Funds made available for 
malaria interventions both domestically 
and internationally were compiled 
from a diverse array of sources. Missing 
data were approximated using dummy 
figures based on conservative, region-
specific averages.
These total investments were 
then applied to a geographic model 
of populations at risk of “stable” 
transmission (PfPAR) [4]. This model 
interpolated clinical observations 
across a population density map, and 
then subtracted areas that climatically 
or topographically fall beyond 
the biological limits of malaria’s 
distribution. This distribution provided 
the denominator for calculating 
investments per person at risk.
The sheer range of per capita 
investments in malaria control is 
startling. While the Republic of the 
Congo, Côte d’Ivoire, and Pakistan 
apply only $US0.11 annually per person 
against malaria, Suriname spends about 
1,500 times more: $US167 per person 
per annum. 
Most countries spend much less 
than what is necessary. In Nigeria, 
where more than 100 million people 
live at risk of malaria, less than $US1 
is invested per person per year, far 
below the $US2.43–$US4.46 per 
capita estimated necessary to achieve 
internationally agreed goals [2,3]. 
Africa overall receives only 10%–20% 
of what it needs to meet basic, globally 
recognized intervention targets.
Asia faces similar neglect. Although 
47% of the global population exposed 
to Plasmodium falciparum malaria resides 
there (38% in India, Indonesia, and 
Myanmar alone), only 17% of funds 
approved by the Global Fund to Fight 
AIDS, Tuberculosis and Malaria were 
designated for Asia. 
The authors describe these shortfalls 
not to assign blame, but to illuminate 
targets where intensified investment 
could produce large returns. With 
a goal as ambitious as halting and 
beginning to reverse malaria incidence 
by 2015, the world can’t afford to 
underfund large populations at risk.
Complications and Limitations
Those who know malaria also know 
the challenges of collecting reliable 
and complete data. Thus, any estimates 
that show inequity deserve closer 
examination. While the PfPAR model 
might provide the most accurate 
depiction yet created of the distribution 
of malaria’s burden, the lack of 
available data impairs the accuracy of 
its interpolations. The simple index 
used to define populations at risk 
(absent, stable, unstable) discounts 
heterogeneities that affect the 
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Linked Research Article
This Perspective discusses the following 
new study published in PLoS Medicine: 
Snow RW, Guerra CA, Mutheu JJ, Hay SI 
(2008) International funding of malaria 
control in relation to populations at 
risk of stable Plasmodium falciparum 
transmission. PLoS Med 5(7): e142. 
doi:10.1371/journal.pmed.0050142
To reach global malaria control goals, 
Robert Snow and colleagues argue that 
more international funding is needed 
but that it must be targeted at specific 
countries most at risk.
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severity of disease and the success of 
interventions. For example, it may cost 
more to protect a child in Southern 
Benin, where pyrethroid resistance 
hampers the efficacy of long-lasting 
insecticidal nets (LLINs) [5], or in 
Niger, where bed-net use among 
pregnant mothers remains below 
50% despite a national campaign to 
distribute and promote bed-net use 
among high-risk groups [6]. Similarly, 
equal per capita investments between 
countries can disguise inequities. 
Is the True Gap Wider?
In retrospect, prior estimates of need 
[3,4,7] now seem limited in their 
choice of intervention methods and 
optimistic in anticipation of outcomes 
and challenges. Do their assumptions 
remain valid? Might the true gap 
between commitments and allocations 
be even wider than this study suggests?
Besides pyrethroid resistance 
and barriers to the use of LLINs 
mentioned above [5,6], other 
operational challenges have arisen 
that could increase costs beyond 
original estimates. Some places report 
adaptations by mosquito vectors toward 
outdoor or early evening feeding, 
which allows them to evade contact 
with LLINS or walls treated with indoor 
residual spraying [8]. Artemisinin-
based combination therapies 
employing mefloquine are failing 
on the Thailand–Cambodia border 
[9]. When such complications arise, 
reaching burden reduction targets 
becomes even more expensive.
Are Plans for Elimination 
Premature?
Despite the inability of the 
international community to mobilize 
resources sufficient to meet basic goals, 
talk of elimination and eradication 
has again become fashionable. But 
until shortfalls in funding are rectified, 
such plans seem quixotic at best. And 
more will be needed in the future 
than merely increased funding. Fully 
implemented, the current standard 
suite of intervention methods may 
suffice to reach burden reduction 
targets, but elimination requires 
strategies that can reach above the 
lowest hanging fruit.
There’s no need to wait for a 
vaccine. Underused technologies 
exist that could reinforce standard 
interventions. But these strategies 
require integration in a manner not 
currently practiced on a wide scale. 
Evidence continues to mount for 
the value of methods such as habitat 
modification and source reduction 
[10], simple housing improvements 
[11], and personal repellents [12]. 
Each may not be globally scalable, 
but their situational value is clear, not 
only for elimination programs, but 
to achieve burden reduction goals 
wherever standard approaches prove 
lacking. 
Summary
Robert Snow and colleagues marshal 
the best data yet on the finances of 
global malaria intervention, but their 
work provides a basis, not an endpoint, 
for discussion. To achieve Goal 6 of the 
Millennium Development Goals, the 
gap between needs and commitments 
must be filled quickly. Given recent 
calls for malaria eradication [13], 
Snow and colleagues’ sober assessment 
should provide an instrument to prod 
the horse on before the cart disappears 
too far down the road.  
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